TRAXV icon

First Tracks (TRAXV)

NASDAQ

$0.00

(

0.00%

)

1D
5D
1M
6M
1Y
5Y
Market open

TRAXV: $0.00 / ₿ 0 BTC / 0 Sats

1D
5D
1M
6M
1Y
5Y

Key statistics

$19.00 - $24.20
$32.00
34.75M
$16.97 - $27.00
No

What is First Tracks (TRAXV)?

First Tracks Biotherapeutics Inc is a clinical-stage biotechnology company focused on delivering immunology therapeutics for autoimmune and inflammatory diseases. Its clinical-stage pipeline includes rosnilimab, a selective pathogenic T cell depleter, for which it completed a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA), ANB033, a CD122 antagonist, in a Phase 1b trial for celiac disease (CeD) and eosinophilic esophagitis (EoE), and ANB101, a BDCA2 modulator, in a Phase 1a trial. The company operates in one reportable segment focused on research and development activities to deliver immunology therapeutics for autoimmune and inflammatory diseases.

The First Tracks (TRAXV) stock price has been falling

The First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued (TRAXV) stock price today is $0.00, reflecting a 0.00% move since the market opened. The company’s market capitalization stands at , with a daily trading volume of $32.00 shares. The previous closing price was .

Get started with First Tracks (TRAXV)

Ready to get started? Follow the steps below, or read our guide on how to buy First Tracks stock on Kraken starting from $10.

Create an account

Create an account

Open the Kraken app to confirm your eligibility and follow the steps for account verification.



Deposit funds

Deposit funds

Once your account has been verified and stock trading is unlocked, you can deposit funds into your account using your preferred payment method.

Buy

Buy TRAXV

Search for TRAXV in the Kraken app, enter the amount you want to invest, review the important details and tap Confirm to place an order to buy TRAXV.

TRAXV FAQs

TRAXV is in the Healthcare sector. Sector is a broad classification that groups companies based on their business activities, industry focus or economic function.

TRAXV is in the Biotechnology industry. Industry is a more specific classification within a sector, grouping companies that operate in a similar field and have closely related business models.

Over the past 52 weeks, First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued (TRAXV) has traded between a low of $19.00 and a high of $24.20.

TRAXV is in the Biotechnology industry group. Industry group is a further subdivision within an industry, grouping companies with even more closely related business models and operations. This helps investors analyze stocks at a more detailed level than sector and industry classifications alone.

Want to invest in First Tracks? 
Get the Kraken app

Eligible US clients can now invest in over 11,000 stocks and ETFs - commission-free* - directly in the Kraken app. Download it and get started.

Fictional stock
USD icon
USD
TRAXV icon
TRAXV

Only available to USA clients through the Kraken app
or Kraken Pro.

Get the Kraken Pro app and buy First Tracks in minutes

Kraken App QR Code

Explore other stocks

Most active

Explore the most-traded stocks today

ARAI icon

ARAI

YMT icon
ONCO icon

ONCO

Top gainers

Browse today’s biggest stock market winners

LICYQ icon

LICYQ

RUBI icon

RUBI

BBIG icon

Top losers

Compare the worst-performing stocks of 
the day

YOTAR icon

YOTAR

EPWKF icon
AFMDQ icon

AFMDQ

Want to learn more about equities?

Check out our Kraken Learn Center guides

Currently available in the U.S. only; may not be available in all states. Brokerage services are provided by Kraken Securities LLC, member FINRA/SIPC. Please view the firm’s profile, registration and background of our registered reps on https://brokercheck.finra.org/. Digital asset services offered by Payward Interactive, not a member of FINRA/ SIPC and not FDIC insured. This is not an offer, solicitation, inducement or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Kraken Securities is not registered. All trading involves risk, including loss of your investments. View full disclosures at: Equities Disclosures and Crypto Risk Disclosures.

*Other applicable fees may apply.